Levalbuterol is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Levalbuterol Hydrochloride.
Product ID | 0093-4146_43e2d0a6-b135-41c9-b92c-abdc008041ae |
NDC | 0093-4146 |
Product Type | Human Prescription Drug |
Proprietary Name | Levalbuterol |
Generic Name | Levalbuterol |
Dosage Form | Solution |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2013-04-29 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA090297 |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Substance Name | LEVALBUTEROL HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/3mL |
Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-01-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA090297 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-04-29 |
Marketing Category | ANDA |
Application Number | ANDA090297 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2013-04-29 |
Marketing End Date | 2019-12-31 |
Marketing Category | ANDA |
Application Number | ANDA090297 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-01-07 |
Marketing Category | ANDA |
Application Number | ANDA090297 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-01-04 |
Ingredient | Strength |
---|---|
LEVALBUTEROL HYDROCHLORIDE | .63 mg/3mL |
SPL SET ID: | f3ce78d9-e923-400e-b3cd-3e6124ac7f6d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |